Venous thrombosis and obesity: from clinical needs to therapeutic challenges

Nutter S, Eggerichs LA, Nagpal TS, Ramos Salas X, Chin Chea C, Saiful S, Ralston J, Barata-Cavalcanti O, Batz C, Baur LA, Birney S, Bryant S, Buse K, Cardel MI, Chugh A, Cuevas A, Farmer M, Ibrahim A, Kataria I, Kotz C, Kyle T, le Brocq S, Mooney V, Mullen C, Nadglowski J, Neveux M, Papapietro K, Powis J, Puhl RM, Rea Ruanova B, Saunders JF, Stanford FC, Stephen O, Tham KW, Urudinachi A, Vejar-Renteria L, Walwyn D, Wilding J, Yusop S (2024) Changing the global obesity narrative to recognize and reduce weight stigma: a position statement from the World Obesity Federation. Obes Rev 25:e13642. https://doi.org/10.1111/obr.13642

Article  PubMed  Google Scholar 

Despres JP, Carpentier AC, Tchernof A, Neeland IJ, Poirier P (2021) Management of obesity in cardiovascular practice: JACC focus seminar. J Am Coll Cardiol 78:513–531. https://doi.org/10.1016/j.jacc.2021.05.035

Article  PubMed  PubMed Central  Google Scholar 

Khan F, Tritschler T, Kahn SR, Rodger MA (2021) Venous thromboembolism. Lancet 398:64–77. https://doi.org/10.1016/S0140-6736(20)32658-1

Article  CAS  PubMed  Google Scholar 

Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 20:248–262. https://doi.org/10.1038/s41569-022-00787-6

Article  PubMed  Google Scholar 

French SA, Lutsey PL, Rosamond W, MacLehose RF, Cushman M, Folsom AR (2020) Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort. Int J Obes (Lond) 44:2465–2471. https://doi.org/10.1038/s41366-020-00674-5

Article  CAS  PubMed  Google Scholar 

Busetto L, Dicker D, Fruhbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH (2024) A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. https://doi.org/10.1038/s41591-024-03095-3

Article  PubMed  Google Scholar 

Klarin D, Emdin CA, Natarajan P, Conrad MF, Consortium I, Kathiresan S (2017) Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet. https://doi.org/10.1161/CIRCGENETICS.116.001643

Article  PubMed  PubMed Central  Google Scholar 

Lindstrom S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, de Haan HG, Chasman D, Ridker P, Brody J, de Andrade M, Heit JA, Tang W, DeVivo I, Grodstein F, Smith NL, Tregouet D, Kabrhel C, Consortium I (2017) Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian randomization study. Hum Genet 136:897–902. https://doi.org/10.1007/s00439-017-1811-x

Article  PubMed  PubMed Central  Google Scholar 

Morange PE, Alessi MC (2013) Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology. Thromb Haemost 110:669–680. https://doi.org/10.1160/TH13-01-0075

Article  CAS  PubMed  Google Scholar 

Mohammadian Khonsari N, Khashayar P, Shahrestanaki E, Kelishadi R, Mohammadpoor Nami S, Heidari-Beni M, Esmaeili Abdar Z, Tabatabaei-Malazy O, Qorbani M (2022) Normal weight obesity and cardiometabolic risk factors: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 13:857930. https://doi.org/10.3389/fendo.2022.857930

Article  PubMed  Google Scholar 

Abiri B, Koohi F, Ebadinejad A, Valizadeh M, Hosseinpanah F (2022) Transition from metabolically healthy to unhealthy overweight/obesity and risk of cardiovascular disease incidence: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 32:2041–2051. https://doi.org/10.1016/j.numecd.2022.06.010

Article  PubMed  Google Scholar 

Opio J, Wynne K, Attia J, Hancock S, Oldmeadow C, Kelly B, Inder K, McEvoy M (2023) Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter community study. Int J Obes (Lond) 47:117–125. https://doi.org/10.1038/s41366-022-01241-w

Article  PubMed  Google Scholar 

Jang H, Kim R, Lee JT, Lee DH, Giovannucci EL, Oh H (2023) Overall and abdominal obesity and risks of all-cause and cause-specific mortality in Korean adults: a pooled analysis of three population-based prospective cohorts. Int J Epidemiol 52:1060–1073. https://doi.org/10.1093/ije/dyac242

Article  PubMed  Google Scholar 

Cermakova E, Forejt M (2024) Metabolically healthy obesity and health risks: a review of meta-analyses. Cent Eur J Public Health 32:3–8. https://doi.org/10.21101/cejph.a7806

Article  PubMed  Google Scholar 

King A, Graham CA, Glaister M, Da Silva AV, Pilic L, Mavrommatis Y (2023) The efficacy of genotype-based dietary or physical activity advice in changing behavior to reduce the risk of cardiovascular disease, type II diabetes mellitus or obesity: a systematic review and meta-analysis. Nutr Rev 81:1235–1253. https://doi.org/10.1093/nutrit/nuad001

Article  PubMed  Google Scholar 

Cao LN, Wang YY, Hou XY, Zheng HD, Wei RZ, Zhao RR, Shen WY, Yang Y, Chu JF, Tian GY, Xiao J, Tian T (2024) New insights on the association of weight loss with the reduction in carotid intima-media thickness among patients with obesity: an updated systematic review and meta-analysis. Public Health 226:248–254. https://doi.org/10.1016/j.puhe.2023.11.013

Article  CAS  PubMed  Google Scholar 

Wang L, Ding H, Deng Y, Huang J, Lao X, Wong MCS (2024) Associations of obesity indices change with cardiovascular outcomes: a dose-response meta-analysis. Int J Obes (Lond) 48:635–645. https://doi.org/10.1038/s41366-024-01485-8

Article  PubMed  Google Scholar 

de Oliveira AG, Nienkotter TF, Balieiro CCA, Pasqualotto E, Cintra JB, Carvalho HCP, Silva ALS, Kabariti JC, Minucci BS, Bertoli ED, Guida CM (2024) Cardiovascular benefits of GLP-1 receptor agonists in patients living with obesity or overweight: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. https://doi.org/10.1007/s40256-024-00647-3

Article  Google Scholar 

Neeland IJ, Poirier P, Despres JP (2018) Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation 137:1391–1406. https://doi.org/10.1161/CIRCULATIONAHA.117.029617

Article  PubMed  PubMed Central  Google Scholar 

Blokhin IO, Lentz SR (2013) Mechanisms of thrombosis in obesity. Curr Opin Hematol 20:437–444. https://doi.org/10.1097/MOH.0b013e3283634443

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415–3422. https://doi.org/10.1182/blood-2013-05-427708

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu D, Jia X, Cui L, Liu J, Chen J, Wang Y, Niu W, Xu J, Miller MR, Loh M, Deng F, Guo X (2021) Exposure to fine particulate matter promotes platelet activation and thrombosis via obesity-related inflammation. J Hazard Mater 413:125341. https://doi.org/10.1016/j.jhazmat.2021.125341

Article  CAS  PubMed  Google Scholar 

Goudswaard LJ, Corbin LJ, Burley KL, Mumford A, Akbari P, Soranzo N, Butterworth AS, Watkins NA, Pournaras DJ, Harris J, Timpson NJ, Hers I (2022) Higher body mass index raises immature platelet count: potential contribution to obesity-related thrombosis. Platelets 33:869–878. https://doi.org/10.1080/09537104.2021.2003317

Article  CAS  PubMed  Google Scholar 

Hall R, Suarez S, Majumdar M, Lee I, Zacharias N, Gee D, Dua A (2024) Thromboelastography with platelet mapping identifies high platelet reactivity is associated with obesity, diabetes, and thrombotic events. Ann Vasc Surg 104:227–236. https://doi.org/10.1016/j.avsg.2023.12.079

Article  PubMed  Google Scholar 

Petrucci G, Zaccardi F, Giaretta A, Cavalca V, Capristo E, Cardillo C, Pitocco D, Porro B, Schinzari F, Toffolo G, Tremoli E, Rocca B (2019) Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation. J Thromb Haemost 17:885–895. https://doi.org/10.1111/jth.14445

Article  CAS  PubMed  Google Scholar 

Vignini A, Nanetti L, Moroni C, Testa R, Sirolla C, Marra M, Cenerelli S, Gregori A, Fumelli D, Olivieri F, Mazzanti L, Rabini RA (2008) Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia. Nutr Metab Cardiovasc Dis 18:553–558. https://doi.org/10.1016/j.numecd.2007.08.001

Article  CAS  PubMed  Google Scholar 

Schneider DJ, Hardison RM, Lopes N, Sobel BE, Brooks MM, Pro-Thrombosis Ancillary Study G (2009) Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. Diabetes Care 32:944–949. https://doi.org/10.2337/dc08-1308

Article  CAS 

留言 (0)

沒有登入
gif